News About: Pharm. Industry
Four drugmakers win prizes for R&D capacity and global competitiveness
Four Korean pharmaceutical companies, such as Green Cross, LG Life Sciences, Daewoong Pharm and Boryung Pharm, won highest honors as 2013 innovative drug firms at the Farm Fair of Bio Korea held at KINTEX in Goyang, G...
Green Cross seals partnership with Alvogen
Green Cross has signed a memorandum of understanding at its headquarters at Yongin, Gyeonggi Province, to explore a possible strategic collaboration with U.S.-based generic firm Alvogen, company officials said last Th...
DHP Korea seeks overseas expansion
DHP Korea, a local ophthalmological maker, is seeking overseas expansion, after the recent inspection of its GMP-compliant Osong plant in North Chungcheong Province was conducted by Walgreens, the largest drug retaili...
Korean drug makers set sights on overseas market
Korean pharmaceutical companies are looking to overseas markets in order to seek new profit engines, industry data showed recently.
According to data by Yakup.com, a pharmaceutical information portal, the combined ...
Jiansu hosts Korean companies
Jiansu, which is an eastern coastal province of the People’s Republic of China and borders Shanghai to the south, is rushing to re-invent itself through the establishment of a comprehensive biology cluster of knowledg...
KPMA expels Wales Korea
The Korea Pharmaceutical Manufacturers Association (KPMA) on Wednesday decided to oust the scandal-ridden Wales Korea and other eight drug firms that have failed to pay the membership fees over the prolonged period.
...
Dream Pharma, Roche Korea starts strategic partnership
Dream Pharma, an affiliated company of Hanwha Group, said Tuesday that it has started a strategic partnership with Roche Korea is a Korean subsidiary of F. Hoffmann-La Roche, a research-focused healthcare company head...
Plan to change ‘generic drug’ in Korean draws mixed reactions
The Korea Pharmaceutical Manufacturers Association (KPMA) plans to change the name ‘generic drug’ in Korean to other appropriate name in an effort to dispel any negative public recognition and boost the sales of gener...
Prosecutors demand jail term for Dong-A’s sales executive
The prosecution on Monday demanded a 2-year jail term for Dong-A Pharmaceutical’s sales executive who was involved in the production of educational video for employees of Dong-A.
In the Seoul Central District Court...
Daewoong seeking to clarify controversial efficacy of Ursa
Daewoong Pharm is making all-out to publicize more correct information of Ursa (ursodeoxycholic acid; UCDA) to the public, while dispelling the local media’s recent report that Ursa is a simple digestive, being far fr...